• Subscribe
  • Magazine
  • Past Issues
  • Surveys
  • Industry Statistics
  • About Us
  • Members Only
  • Best Places to Work
    • Recent Quotes
    My Watchlist
    Indicators
    PennEnergy Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Atossa Therapeutics Inc (NQ: ATOS )

    1.340 -0.020 (-1.47%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Jul 19, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 656,341
    Open 1.360
    Bid (Size) 1.330 (2)
    Ask (Size) 1.380 (4)
    Prev. Close 1.360
    Today's Range 1.310 - 1.380
    52wk Range 0.6200 - 2.310
    Shares Outstanding 125,785,200
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    3 Dirt-Cheap Drug Developers With Blockbuster Potential
    These are three of the best cheap drug developer stocks for investors to keep an eye as their growth could be imminent. 
    Via InvestorPlace
    3 Penny Stock Moonshots with 300%+ Upside Potential by 2025
    If you understand the risks of penny stocks with upside, you may want to investigate these three stocks today. 
    Via InvestorPlace

    Performance

    YTD
    +43.32%
    +43.32%
    1 Month
    +19.64%
    +19.64%
    3 Month
    -5.63%
    -5.63%
    6 Month
    +64.22%
    +64.22%
    1 Year
    +25.23%
    +25.23%

    More News

    Read More
    Meme Mania Meets Medicine: 3 Biotech Stocks Primed to Soar
    Via InvestorPlace
    3 Must-Buy Biotech Stocks Before the Summer Rally Kicks Off
    Via InvestorPlace
    Wall Street Favorites: 3 Biotech Stocks with Strong Buy Ratings for May 2024
    Via InvestorPlace
    MicroMarvel - Atossa Therapeutics
    Via Talk Markets
    Atossa Therapeutics backing Endoxifen in the fight against breast cancer
    Via News Direct
    ATOS Stock Earnings: Atossa Therapeutics Beats EPS for Q1 2024
    Via InvestorPlace
    Shhh! 3 Secret Penny Stocks Flying Below Wall Street’s Radar
    Via InvestorPlace
    ATOS Stock Earnings: Atossa Therapeutics Misses EPS for Q4 2023
    Via InvestorPlace
    Catalyst Countdown: 3 Biotech Stocks With Upcoming News That Could Move the Market
    Via InvestorPlace
    This Drug Developer Is Dedicated To "Transforming The Breast Cancer Paradigm"
    Via Benzinga
    Approximately 30% Of Newly Diagnosed Cancers In Women Will Be Breast Cancers - Atossa Therapeutics Has A Promising Drug To Help With Prevention And Treatment
    Via ACCESSWIRE
    Approximately 30% Of Newly Diagnosed Cancers In Women Will Be Breast Cancers – Atossa Therapeutics Has A Promising Drug To Help With Prevention And Treatment
    Via Benzinga
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    Breast Cancer-Focused Atossa Therapeutics Can Possibly Change Treatment Paradigm: Analyst
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For September 8, 2023
    Via Benzinga
    Could Anixa Biosciences (NASDAQ: ANIX) Be Developing The Vaccine To End One Of The Deadliest Types Of Breast Cancer?
    Via Benzinga
    50% Of Women Have Elevated Breast Density, Which Significantly Decreases the Effectiveness of Mammography - Atossa Therapeutics Is Looking To Ensure Earlier, Accurate Diagnosis
    Via ACCESSWIRE
    50% Of Women Have Elevated Breast Density, Which Significantly Decreases The Effectiveness Of Mammography – Atossa Therapeutics Is Looking To Ensure Earlier, Accurate Diagnosis
    Via Benzinga
    3 Penny Stocks to Make Your ‘Get Rich’ Dreams Come True
    Via InvestorPlace
    3 Penny Stocks Set to Pass the $5 Mark Soon
    Via InvestorPlace
    3 Penny Stocks That Could Skyrocket in the Next 12 Months
    Via InvestorPlace
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
    Via InvestorPlace
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.